Australia's INOVIQ rises on Sonic Healthcare pact for ovarian cancer test
BUZZ-Australia's INOVIQ rises on Sonic Healthcare pact for ovarian cancer test ** Shares of Australia's INOVIQ IIQ.AX rise as much as 18.5% to A$0.160, marking their biggest intraday pct gain since June 22
** Shares hit their highest level since October 8
** The biotech firm signs validation and licence option agreement with US unit of Sonic Healthcare SHL.AX for its EXO-OC ovarian cancer early detection test
** Says agreement covers transfer, optimisation and validation of EXO-OC at Sonic Healthcare USA's CAP/CLIA-certified molecular diagnostics laboratory in New York
** Adds deal gives Sonic Healthcare USA an option to pursue a future licence to offer EXO-OC as a laboratory-developed test in the United States
** More than 160,000 shares change hands, about 1.9x the 30-day average
** YTD, INOVIQ stock down 62.6%, including session's moves
(Reporting by Subhalakshmi Dey in Bengaluru)
Recent news on Sonic Healthcare
See all newsAustralia's INOVIQ rises on Sonic Healthcare pact for ovarian cancer test
Cochlear, Sonic Healthcare fall on MSCI Australia Index exit
Australia's Sonic Healthcare slips to near 2-month low as Citi downgrades FY27 estimates
Australia's Sonic Healthcare falls after company flags impact to fiscal 2027 profit
Brief: MSCI Says There Will Be 184 Additions To The MSCI ACWI IMI Index